Literature DB >> 1699353

Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites.

J D Kitson1, D McCahon, G J Belsham.   

Abstract

Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus has been performed. Distinct clusters of amino acid substitutions conferring resistance to neutralization at each of the four previously defined antigenic sites (McCahon et al., 1989, J. Gen. Virol. 70, 639-645) have been identified. One site corresponds to the well-known 140-160 region of VP1, a second site is also on VP1, one site is on VP2, and the fourth site is on VP3. All of the amino acid substitutions identified are located on the surface of the virus. Despite the differences in three-dimensional structure between FMDV and other picornaviruses the neutralizing antigenic sites occur in analogous positions on the capsid surface.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699353     DOI: 10.1016/0042-6822(90)90269-w

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  61 in total

1.  Characterization of the structural-protein-coding region of SAT 2 type foot-and-mouth disease virus.

Authors:  H G van Rensburg; L H Nel
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  Molecular epidemiology of serotype O foot-and-mouth disease virus with emphasis on West and South Africa.

Authors:  O Sangare; A D Bastos; O Marquardt; E H Venter; W Vosloo; G R Thomson
Journal:  Virus Genes       Date:  2001-06       Impact factor: 2.332

Review 3.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

4.  Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.

Authors:  J C Saiz; M J Gonzalez; M V Borca; F Sobrino; D M Moore
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

5.  Nucleotide sequence of the P1 region of foot-and-mouth disease virus strain O1 Caseros.

Authors:  C Tami; G Kaplan; M E Piccone; E L Palma
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

6.  Antigenic variability of foot-and-mouth disease virus serotype O during serial cytolytic passage.

Authors:  Saravanan Subramaniam; Biswajit Das; Jitendra K Biswal; Rajeev Ranjan; Bramhadev Pattnaik
Journal:  Virus Genes       Date:  2017-07-17       Impact factor: 2.332

7.  Antigenic stability of foot-and-mouth disease virus variants on serial passage in cell culture.

Authors:  M J Gonzalez; J C Saiz; O Laor; D M Moore
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

8.  Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus.

Authors:  J R Crowther; C A Rowe; R Butcher
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

9.  Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.

Authors:  M G Mateu; J Hernández; M A Martínez; D Feigelstock; S Lea; J J Pérez; E Giralt; D Stuart; E L Palma; E Domingo
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Emergence of a new strain of type O foot-and-mouth disease virus: its phylogenetic and evolutionary relationship with the PanAsia pandemic strain.

Authors:  Divakar Hemadri; Chakradhar Tosh; Aniket Sanyal; Ramamurthy Venkataramanan
Journal:  Virus Genes       Date:  2002       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.